Buy Butylone Quality Drug Online (also known as β-keto-N-methylbenzodioxolylbutanamine, βk-MBDB, or B1) is a synthetic entactogen and stimulant of the phenethylamine and cathinone classes. Butylone (also known as β-keto-N-methylbenzodioxolylbutanamine, βk-MBDB, or B1) is a synthetic entactogen and stimulant of the phenethylamine and cathinone classes. Butylone is the β-keto analog of MBDB and the substituted methylenedioxy analogue of buphedrone.
Methylbenzodioxolylbutanamine (MBDB, Item No. 14218) is an analog of ecstasy (methylenedioxymethamphetamine) that shares its psychotropic activities. Butylone (hydrochloride) is a β-keto derivative of MBDB that has been identified in designer drugs sold as bath salts.1,2 The β-keto moiety in this structural context defines this compound as a cathinone. This product is intended to be used for forensic applications
What is Butylone?
It is also known as β-keto-N-methylbenzodioxolylbutanamine (bk-MBDB), is an entactogen, psychedelic, and stimulant of the phenethylamine chemical class. It is the β-keto analogue of MBDB.
It has been defined as an entactogen, stimulant, and psychedelic. It belongs to the phenethylamine class.Butylone is also said to be a β-keto analog of MBDB. Butylone has a relationship to another research chemical – MBDB. Some chemical suppliers of bk-MBDB say they have received some reports from people who take this research chemical orally and in rare cases nasally to achieve special state of consciousness usually associated with drugs.
It was first synthesized by Koeppe, Ludwig, and Zeile which is mentioned in their 1967 paper. It remained an obscure product of academia until 2005 when it was synthesized by a chemical supply company, and has since continued to be sold as a research chemical. It has since been explored as a possible entheogen. Butylone shares the same relationship to MBDB as methylone does to MDMA (“Ecstasy”). The dosage range is not fully understood but seems to be lower than for MBDB. Formal research on this chemical was first conducted in 2009, when it was shown to be metabolized in a similar manner to related drugs like methylone.